Frontlight ResearchEarly access
Active, not recruitingNo phase
CoreHip - Post Market Clinical Follow-Up Study
Key facts
- Who runs it
- Aesculap AG
- Where
- Germany and Switzerland6 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 248 people enrolled
- Started
- 16 Oct 2018
- Expected to end
- Dec 2028
- Type of study
- Observational
- Treatments tested
- CoreHip Total Hip Arthroplasty
- Record updated
- 31 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patient age ≥ 18 years
- Indication for THA with a CoreHip® stem
- Written informed consent
Who cannot take part
- Patient age < 18 years
- Pregnancy
- Patient not able to regularly participate at the follow-up examinations
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.
The group in the trial
- CoreHip
Clinical and Radiological Data of 300 patients of a Standard Patient Population, who are treated with CoreHip Total Hip Arthroplasty for Indications according to the Instructions for Use (IfU) with a five year follow Up
Treatment: CoreHip Total Hip Arthroplasty
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective, Non-Interventional, Multicenter, Post-Market Clinical Follow-up Study CoreHip®
- Record updated
- 31 March 2026